Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid

Journal of Alzheimer's Disease

Volumn 5, Issue 3, 2003, Pages 229-239

  Lovell, Mark A ^a,b   Xie, Chengsong ^a   Xiong, Shuling ^a   Markesbery, William R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Antioxidants; Free radicals; Lipid peroxidation; Neuron cultures

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; DIHYDROLIPOATE; FREE RADICAL; HYDROGEN PEROXIDE; IRON; THIOCTIC ACID;

AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME MECHANISM; FLUORESCENCE; GLUCOSE TRANSPORT; HIPPOCAMPUS; HUMAN; LIPID PEROXIDATION; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0142010609     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2003-5306     Document Type: Article

References (81)

1. M.E. Anderson, F. Powrie, R.N. Puri and A. Meister, Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione, Arch Biochem Biophys 239 (1985), 538-548.
2. L. Androne, N.A. Gavan, I.A. Veresiu and R. Orasan, In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy, In Vivo 14 (2000), 327-330.
3. A. Bast and G.R. Haenen, Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation, Biochim Biophys Acta 963 (1988), 558-561.
4. A. Bast and G.R. Haenen, Regulation of lipid peroxidation by glutathione and lipoic acid: involvement of liver microsomal vitamin E free radical reductase, Adv Exp Med Biol 264 (1990), 111-116.
5. F. Bonomi and S. Pagani, Removal of ferritin-bound iron by DL-dihydrolipoate and DL-dihydrolipoamide, Eur J Biochem 155 (1986), 295-300.
6. F. Bonomi, S. Pagani, F. Cariati, A. Pozzi, G. Crisponi, F. Cristiani, V. Nurchi, U. Russo and R. Zanoni, Synthesis and characteriztion of iron derivatives of dihydrolipoic acid and dihydrolipoamide, Inorgan. Chim. Acta 195 (1992), 109-115.
7. A. Boveris, E.J.A. Roldan and S. Alvarez, Effect of lipoic acid on short-term ischemia-reperfusion in rat intestine, in: Biological oxidants and antioxidants, L. Packer and E. Cadenas, eds, Verlag, Stuttgart, 1994.
8. N.Y. Calingasan, K. Uchida and G.E. Gibson, Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease, J Neurochem 72 (1999), 751-756.
9. J.P. Carreau, Biosynthesis of lipoic acid via unsaturated fatty acids, Methods Enzymol 62 (1979), 152-158.
10. C.R. Cornett, W.R. Markesbery and W.D. Ehmann, Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain, Neurotoxicology 19 (1998), 339-345.
11. J.T. Coyle and P. Puttfarcken, Oxidative stress, glutamate, and neurodegenerative disorders, Science 262 (1993), 689-695.
12. T.P. Devasagayam, P. Di Mascio, S. Kaiser and H. Sies, Singlet oxygen induced single-strand breaks in plasmid pBR322 DNA: the enhancing effect of thiols, Biochim Biophys Acta 1088 (1991), 409-412.
13. T.P. Devasagayam, M. Subramanian, D.S. Pradhan and H. Sies, Prevention of singlet oxygen-induced DNA damage by lipoate, Chem Biol Interact 86 (1993), 79-92.
14. W.D. Ehmann, W.R. Markesbery, M. Alauddin, T.I. Hossain and E.H. Brubaker, Brain trace elements in Alzheimer's disease, Neurotoxicology (1986), 195-206.
15. S.P. Gabbita, M.Y. Aksenov, M.A. Lovell and W.R. Markesbery, Decrease in peptide methionine sulfoxide redactase in Alzheimer's disease brain, J Neurochem 73 (1999), 1660-1666.
16. S.P. Gabbita, M.A. Lovell and W.R. Markesbery, Increased nuclear DNA oxidation in the brain in Alzheimer's disease, J Neurochem 71 (1998), 2034-2040.
17. V.M. Gandhi, S.S. Wagh, C.V. Natraj and K.K.G. Menon, Lipoic acid and diabetes II: Mode of action of lipoic acid, J. Biosci. (1985), 117-127.
18. F.K. Gleason and A. Holmgren, Thioredoxin and related proteins in procaryotes, FEMS Microbiol Rev 4 (1988), 271-297.
19. P.F. Good, P. Werner, A. Hsu, C.W. Olanow and D.P. Perl, Evidence of neuronal oxidative damage in Alzheimer's disease, Am J Pathol 149 (1996), 21-28.
20. E. Haak, K.H. Usadel, K. Kusterer, P. Amini, R. Frommeyer, H.J. Tritschler and T. Haak, Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy, Exp Clin Endocrinol Diabetes 108 (2000), 168-174.
21. G.R. Haenen and A. Bast, Scavenging of hypochlorous acid by lipoic acid, Biochem Pharmacol 42 (1991), 2244-2246.
22. G.J. Handelman, D. Han, H. Tritschler and L. Packer, Alphalipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium, Biochem Pharmacol 47 (1994), 1725-1730.
23. E.H. Harrison and D.B. McCormick, The metabolism of dl-(1,6-14C)lipoic acid in the rat, Arch Biochem Biophys 160 (1974), 514-522.
24. N. Haugaard and E.S. Haugaard, Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro, Biochim Biophys Acta 222 (1970), 583-586.
25. K. Hensley, N. Hall, R. Subramaniam, P. Cole, M. Harris, M. Aksenov, M. Aksenova, S.P. Gabbita, J.F. Wu and J.M. Carney et al., Brain regional correspondence between A Izheimer's disease histopathology and biomarkers of protein oxidation, J Neurochem 65 (1995), 2146-2156.
26. A. Holmgren, Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide, J Biol Chem 254 (1979), 9627-9632.
27. S. Jacob, P. Ruus, R. Hermann, H.J. Tritschler, E. Maerker, W. Renn, H.J. Augustin, G.J. Dietze and K. Rett, Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial, Free Radic Biol Med 27 (1999), 309-314.
28. V.E. Kagan, A. Shvedova, E. Serbinova, S. Khan, C. Swanson, R. Powell and L. Packer, Dihydrolipoic acid - a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals, Biochem Pharmacol 44 (1992), 1637-1649.
29. J.Y. Koh and D.W. Choi, Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay, J Neurosci Methods 20 (1987), 83-90.
30. M.A. Lovell, W.D. Ehmann, S.M. Butler and W.R. Markesbery, Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease, Neurology 45 (1995), 1594-1601.
31. M.A. Lovell, W.D. Ehmann, M.P. Mattson and W.R. Markesbery, Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease, Neurobiol Aging 18 (1997), 457-461.
32. M.A. Lovell, C. Xie, S.P. Gabbita and W.R. Markesbery, Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain, Free Radic Biol Med 28 (2000), 418-427.
33. M.A. Lovell, C. Xie and W.R. Markesbery, Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures, Neurobiol Aging 22 (2001), 187-194.
34. M.A. Lovell, C. Xie and W.R. Markesbery, Decreased base excision repair and increased helicase activity in Alzheimer's disease brain, Brain Res 855 (2000), 116-123.
35. M.A. Lovell, C. Xie and W.R. Markesbery, Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease, Neurology 51 (1998), 1562-1566.
36. P.A. Low and K.K. Nickander, Oxygen free radical effects in sciatic nerve in experimental diabetes, Diabetes 40 (1991), 873-877.
37. R.J. Mark, Z. Pang, J.W. Geddes, K. Uchida and M.P. Mattson, Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation, J Neurosci 17 (1997), 1046-1054.
38. W.R. Markesbery, Oxidative stress hypothesis in Alzheimer's disease, Free Radic Biol Med 23 (1997), 134-147.
39. W.R. Markesbery, The role of oxidative stress in Alzheimer disease, Arch Neurol 56 (1999), 1449-1452.
40. W.R. Markesbery and J.M. Carney, Oxidative alterations in Alzheimer's disease, Brain Pathol 9 (1999), 133-146.
41. W.R. Markesbery and M.A. Lovell, Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease, Neurobiol Aging 19 (1998), 33-36.
42. A. Martin, D. Janigian, B. Shukitt-Hale, R.L. Prior and J.A. Joseph, Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations, Brain Res 845 (1999), 50-59.
43. P. Mecocci, U. MacGarvey and M.F. Beal, Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease, Ann Neurol 36 (1994), 747-751.
44. P. Mecocci, U. MacGarvey, A.E. Kaufman, D. Koontz, J.M. Shoffner, D.C. Wallace and M.F. Beal, Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain, Ann Neurol 34 (1993), 609-616.
45. T.J. Montine, W.R. Markesbery, J.D. Morrow and L.J. Roberts, 2nd, Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease, Ann Neurol 44 (1998), 410-413.
46. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal, R.S. Wilson and P.A. Scherr, Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study, Jama 287 (2002), 3230-3237.
47. C.B. Natraj, V.M. Gandhi and K.K.G. Menon, Lipoic acid and diabetes: Effect of dihydrolipoic acid administration diabetic rats and rabbits, J. Biosci. 6 (1984), 37-46.
48. P. Ou, H.J. Tritschler and S.P. Wolff, Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 50 (1995), 123-126.
49. L. Packer, H.J. Tritschler and K. Wessel, Neuroprotection by the metabolic antioxidant alpha-lipoic acid, Free Radic Biol Med 22 (1997), 359-378.
50. L. Packer, E.H. Witt and H.J. Tritschler, alpha-Lipoic acid as a biological antioxidant, Free Radic Biol Med 19 (1995), 227-250.
51. M. Podda, H.J. Tritschler, H. Ulrich and L. Packer, Alpha-lipoic acid supplementation prevents symptoms of vitamin E deficiency, Biochem Biophys Res Commun 204 (1994), 98-104.
52. M.R. Prasad, M.A. Lovell, M. Yatin, H. Dhillon and W.R. Markesbery, Regional membrane phospholipid alterations in Alzheimer's disease, Neurochem Res 23 (1998), 81-88.
53. J.H. Prehn, C. Karkoutly, J. Nuglisch, B. Peruche and J. Krieglstein, Dihydrolipoate reduces neuronal injury after cerebral ischemia, J Cereb Blood Flow Metab 12 (1992), 78-87.
54. D.B.G. Reed, I.C. Gunsalus and C.S. Hornberger, Jr., Crystalline alpha-lipoic acid: a catalytic agent associated with pryvate dehydrogenase, Science 114 (1951), 93-94.
55. M. Reljanovic, G. Reichel, K. Rett, M. Lobisch, K. Schuette, W. Moller, H.J. Tritschler and H. Mehnert, Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alphalipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy, Free Radic Res 31 (1999), 171-179.
56. E.B. Rimm, M.J. Stampfer, A. Ascherio, E. Giovannucci, G.A. Colditz and W.C. Willett, Vitamin E consumption and the risk of coronary heart disease in men, N Engl J Med 328 (1993), 1450-1456.
57. L.J. Roberts, 2nd, T.J. Montine, W.R. Markesbery, A.R. Tapper, P. Hardy, S. Chemtob, W.D. Dettbarn and J.D. Morrow, Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid, J Biol Chem 273 (1998), 13605-13612.
58. H.R. Rosenberg and R. Culik, Effect of alpha-lipoic acid on vitamin C and vitamin E deficiencies, Arch Biochem Biophys 202 (1959), 86-93.
59. K.J. Ruhnau, H.P. Meissner, J.R. Finn, M. Reljanovic, M. Lobisch, K. Schutte, D. Nehrdich, H.J. Tritschler, H. Mehnert and D. Ziegler, Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy, Diabet Med 16 (1999), 1040-1043.
60. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N Engl J Med 336 (1997), 1216-1222.
61. B.C. Scott, O.I. Aruoma, P.J. Evans, C. O'Neill, A. Van der Vliet, C.E. Cross, H. Tritschler and B. Halliwell, Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation, Free Radic Res 20 (1994), 119-133.
62. E. Serbinova, S. Khwaja, A.Z. Reznick and L. Packer, Thioctic acid protects against ischemia-reperfusion injury in the isolated perfused Langendorff heart, Free Radic Res Commun 17 (1992), 49-58.
63. H. Sigel, B. Prijs, D.B. McCormick and J.C. Shih, Stability and structure of binary and ternary complexes of alpha-lipoate and lipoate derivatives with Mn2+, Cu2+, and Zn2+ in solution, Arch Biochem Biophys 187 (1978), 208-214.
64. H.P. Singh and R.H. Bowman, Effect of DL-alpha-lipoic acid on the citrate concentration and phosphofructokinase activity of perfused hearts from normal and diabetic rats, Biochem Biophys Res Commun 41 (1970), 555-561.
65. C.D. Smith, J.M. Carney, P.E. Starke-Reed, C.N. Oliver, E.R. Stadtman, R.A. Floyd and W.R. Markesbery, Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease, Proc Natl Acad Sci USA 88 (1991), 10540-10543.
66. M.A. Smith, S. Taneda, P.L. Richey, S. Miyata, S.D. Yan, D. Stern, L.M. Sayre, V.M. Monnier and G. Perry, Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc Natl Acad Sci USA 91 (1994), 5710-5714.
67. F.E. Stary, S.J. Jindal and R.W. Murray, Oxidation of alphalipoic acid, J Org Chem 40 (1975), 58-62.
68. B. Stevens, R.D. Small, Jr. and S.R. Perez, The photoperoxidation of unsaturated organic molecules. XIII. O2AG quenching by alpha-tocopherol, Photochem Photobiol 20 (1974), 515-517.
69. S. Stoll, H. Hartmann, S.A. Cohen and W.E. Muller, The potent free radical scavenger alpha-lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits, Pharmacol Biochem Behav 46 (1993), 799-805.
70. S. Stoll, A. Rostock, R. Bartsch, E. Korn, A. Meichelbock and W.E. Muller, The potent free radical scavenger alpha-lipoic acid improves cognition in rodents, Ann N Y Acad Sci 717 (1994), 122-128.
71. I.A. Strokov, E.B. Manukhina, L.Y. Bakhtina, I.Y. Malyshev, G.K. Zoloev, S.I. Kazikhanova and A.S. Ametov, The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapy, Bull Exp Biol Med 130 (2000), 986-990.
72. Y.J. Suzuki, M. Tsuchiya and L. Packer, Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species, Free Radic Res Commun 15 (1991), 255-263.
73. L. Svennerholm and C.G. Gottfries, Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II), J Neurochem 62 (1994), 1039-1047.
74. C.M. Thompson, W.R. Markesbery, W.D. Ehmann, Y.X. Mao and D.E. Vance, Regional brain trace-element studies in Alzheimer's disease, Neurotoxicology 9 (1988), 1-7.
75. S.S. Wagh, V.M. Gandhi, C.V. Natraj and K.K.G. Menon, Lipoic acid and diabetes: Part III. Metabolic role of acetyl dihydrolipoic acid, J. Biosci. 10 (1986), 171-179.
76. S.S. Wagh, C.V. Natraj and K.K.G. Menon, Mode of action of lipoic acid in diabetes, J. Biosci. 11 (1987), 59-74.
77. C. Xie, W.R. Markesbery and M.A. Lovell, Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium, Free Radic Biol Med 28 (2000), 665-672.
78. S.D. Yan, X. Chen, A.M. Schmidt, J. Brett, G. Godman, Y.S. Zou, C.W. Scott, C. Caputo, T. Frappier and M.A. Smith et al., Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress, Proc Natl Acad Sci USA 91 (1994), 7787-7791.
79. L. Zhang, G.Q. Xing, J.L. Barker, Y. Chang, D. Maric, W. Ma, B.S. Li and D.R. Rubinow, Alpha-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway, Neurosci Lett 312 (2001), 125-128.
80. D. Ziegler, M. Hanefeld, K.J. Ruhnau, H. Hasche, M. Lobisch, K. Schutte, G. Kerum and R. Malessa, Treatment of symptomatic diabetic polyneuropathy with the antioxidant alphalipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy, Diabetes Care 22 (1999), 1296-1301.
81. D. Ziegler, M. Reljanovic, H. Mehnert and F.A. Gries, Alphalipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials, Exp Clin Endocrinol Diabetes 107 (1999), 421-430.